Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated at S

Research analysts at StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a research report issued to clients and investors on Wednesday. The brokerage set a “sell” rating on the stock. A number of other research analysts have also recently weighed in on the stock. HC Wainwright cut shares of Oncternal […]

Related Keywords

San Diego , California , United States , Davidf Hale , Jamesb Breitmeyer , , Maxim Group , Goldman Sachs Group Inc , Oncternal Therapeutics Inc , Securities Exchange Commission , Prudential Financial Inc , Mirabella Financial Services , Waypoint Capital Advisors , Richmond Brothers Inc , Oncternal Therapeutics , Get Rating , Capital Acquisition , Capital Management , Exchange Commission , Sachs Group , Financial Services , Capital Advisors , Oncternal Therapeutics Daily , Nasdaq Onct , Conct , Medical , Initiated Coverage , Stocknews Com ,